Verition Fund Management LLC Omeros Corp Put Options Transaction History

Verition Fund Management LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$3.54 - $5.47 $248,154 - $383,447	70,100 Added 228.34%	100,800 $400,000
Q2 2024 Aug 14, 2024	BUY	$3.04 - $4.23 $93,328 - $129,861	30,700 New	30,700 $124,000
Q4 2022 Feb 14, 2023	SELL	$1.75 - $3.96 $19,950 - $45,144	-11,400 Reduced 23.46%	37,200 $84,000
Q3 2022 Nov 14, 2022	BUY	$3.09 - $7.46 $150,174 - $362,556	48,600 New	48,600 $153,000
Q2 2022 Aug 15, 2022	SELL	$1.92 - $6.28 $93,312 - $305,208	-48,600 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$5.07 - $7.2 $110,019 - $156,240	21,700 Added 80.67%	48,600 $292,000
Q4 2021 May 03, 2022	BUY	$5.67 - $8.54 $152,523 - $229,725	26,900 New	26,900 $173,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $378M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.